22 Critically Ill Patients (Adults)

Saturday, April 2, 2011: 1:00 PM-2:15 PM
Trinity Ballroom (Hilton Anatole)
Type: Abstracts
97
Reduction of Endotracheal Tube Biofilms using Antimicrobial Photodynamic Therapy
Merrill A. Biel, MD, PhD, Advanced Photodynamic Technologies, Inc; Chet Sievert, Advanced Photodynamic Technologies, Inc; Nicolas Loebel, PhD, Ondine Research Laboratories; Andreas Rose, PhD, Ondine Research Laboratories; Ron Zimmermann, Advanced Photodynamic Technologies, Inc
98
Incidence and Impact of False Positive Urine Pneumococcal Antigen Screening in Hospitalized Patients
Patrick A. Ryscavage, MD, Northwestern University Feinberg School of Medicine; Gary A. Noskin, MD, Northwestern University Feinberg School of Medicine; Anne Bobb, BS, Pharm, Northwestern Memorial Hospital; Laura Bardowski, BSN, Northwestern Memorial Hospital; Teresa R. Zembower, MD, Northwestern University Feinberg School of Medicine
99
Residence in Long Term Care Facilities as a Risk for HCAP: A Review of Culture Resistance Attributable to Facility as Compared to Antibiotic Selection Pressure
Anup Subedee, MD, The Reading Hospital and Medical Center; Debra Powell, MD, The Reading Hospital and Medical Center; Anthony A. Donato, MD, The Reading Hospital and Medical Center
100
Effect of mouth moisturizers on the antibacterial efficacy of Peridex™ Oral Rinse
Michele J. Anderson, University of Minnesota; Mary E. Horn, University of Minnesota; Ranjani Parthasarathy, 3M; Matt T. Scholz, 3M; Marnie L. Peterson, Ph.D., University of Minnesota
101
Indwelling Devices in ICU Patients and a Revised Method for Calculating Central Line-Associated Bloodstream Infection Rates Based on Total Number of Central Venous Catheters
Trevor Van Schooneveld, University of Nebraska Medical Center; Hayley Faber, University of Nebraska Medical Center; Kyle Cassling, University of Nebraska Medical Center; Kate Tyner, Nebraska Medical Center; Elizabeth R. Lyden, University of Nebraska Medical Center; Mark Rupp, University of Nebraska Medical Center
102
Horizontal reduction of hospital acquired infections in the intensive care unit by replacing bed baths with chlorhexidine impregnated washcloths
Pooja Rajani, MPH, Old Dominion University; Susan Moeslein, RN, MSA, CMSRN, Riverside Regional Medical Center; Patrick Haggerty, MS, MD, DME, Riverside Regional Medical Center
103
Vancomycin therapeutic monitoring in the intensive care setting: Optimizing treatment and reducing adverse events
Thiago Zinsly S. Camargo, MD, Hospital Israelita Albert Einstein (HIAE); Moacyr Silva Jr., Hospital Israelita Albert Einstein (HIAE); Sandra Cristina P. L. Shiramizo, Hospital Israelita Albert Einstein (HIAE); Neide M. Lucinio, Hospital Israelita Albert Einstein (HIAE); Denis F. Moura Jr., Hospital Israelita Albert Einstein (HIAE); Juliana Locatelli, Hospital Israelita Albert Einstein (HIAE); Liliane M. Yamamoto, Hospital Israelita Albert Einstein (HIAE); Carlos Eduardo S. Ferreira, Hospital Israelita Albert Einstein (HIAE); Alexandre R. Marra, Hospital Israelita Albert Einstein (HIAE)